As of 2025-10-17, the Relative Valuation of Medicenna Therapeutics Corp (MDNA.TO) is (0.38) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.90 CAD, the upside of Medicenna Therapeutics Corp based on Relative Valuation is -142.7%.
The range of the Relative Valuation is (0.31) - (0.46) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.0x - 2.9x | 2.4x |
| Forward P/E multiples | 2.0x - 2.9x | 2.4x |
| Fair Price | (0.31) - (0.46) | (0.38) |
| Upside | -134.2% - -151.3% | -142.7% |
| Date | P/E |
| 2025-10-15 | -5.73 |
| 2025-10-14 | -5.86 |
| 2025-10-10 | -5.99 |
| 2025-10-09 | -5.99 |
| 2025-10-08 | -5.86 |
| 2025-10-07 | -5.92 |
| 2025-10-06 | -6.05 |
| 2025-10-03 | -6.31 |
| 2025-10-02 | -6.43 |
| 2025-10-01 | -6.11 |
| 2025-09-30 | -6.24 |
| 2025-09-29 | -6.31 |
| 2025-09-26 | -6.11 |
| 2025-09-25 | -5.99 |
| 2025-09-24 | -6.11 |
| 2025-09-23 | -6.50 |
| 2025-09-22 | -6.37 |
| 2025-09-19 | -6.37 |
| 2025-09-18 | -6.31 |
| 2025-09-17 | -6.43 |
| 2025-09-16 | -6.50 |
| 2025-09-15 | -6.69 |
| 2025-09-12 | -6.75 |
| 2025-09-11 | -6.62 |
| 2025-09-10 | -6.62 |
| 2025-09-09 | -6.75 |
| 2025-09-08 | -6.75 |
| 2025-09-05 | -6.69 |
| 2025-09-04 | -6.75 |
| 2025-09-03 | -6.62 |
| 2025-09-02 | -6.75 |
| 2025-08-29 | -6.94 |
| 2025-08-28 | -6.69 |
| 2025-08-27 | -6.88 |
| 2025-08-26 | -7.13 |
| 2025-08-25 | -7.26 |
| 2025-08-22 | -7.01 |
| 2025-08-21 | -7.13 |
| 2025-08-20 | -6.94 |
| 2025-08-19 | -6.81 |
| 2025-08-18 | -6.62 |
| 2025-08-15 | -6.88 |
| 2025-08-14 | -6.88 |
| 2025-08-13 | -6.37 |
| 2025-08-12 | -6.75 |
| 2025-08-11 | -7.07 |
| 2025-08-08 | -7.58 |
| 2025-08-07 | -6.43 |
| 2025-08-06 | -6.24 |
| 2025-08-05 | -5.73 |